EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine

Ariadna Grinyo-Escuer, Srikar Reddy, Agnes L Chenine, J Charles Whitbeck, Sonya Jacobsen, Allison Sheetz, Kyle Doolan, Diana M Norden, Nolan Frey, Frederick W Holtsberg, M Javad Aman, Katja Fink und 5 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Ariadna Grinyo-Escuer und 16 weiteren Autor:innen. Beteiligte Einrichtung: Integral Molecular, Inc., Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Zika Virus, Dengue Virus, Zika Virus Infection, Viral Vaccines. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika VirusDengue VirusZika Virus InfectionViral VaccinesAnimalsCross ReactionsMiceAntibodies, MonoclonalAntibodies, ViralViral Envelope ProteinsHumansAntibodies, NeutralizingEpitopesMice, Inbred BALB CFemaleDengue

Stichwörter der Autor:innen

CP: ImmunologyCP: Microbiologyantibody enhancementantigen engineeringepitope mappingimmunogenic cross-reactivityvirus envelope

Substanzen

Antibodies, MonoclonalAntibodies, ViralViral Envelope ProteinsViral VaccinesAntibodies, NeutralizingEpitopes

Autor:innen und Institutionen

  • Integral Molecular, Inc., Philadelphia, PA, USA.
  • IBT Bioservices, Rockville, MD, USA.
  • Singapore Immunology Network (SIgN), Agency for Science Technology and Research (A(∗)STAR), Singapore, Singapore.
  • Departments of Medicine, Molecular Microbiology, and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Pediatrics, Section of Infectious Diseases, Tulane University School of Medicine, New Orleans, LA, USA.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Grinyo-Escuer, A., Reddy, S., Chenine, A. L., Whitbeck, J. C., Jacobsen, S., Sheetz, A., Doolan, K., Norden, D. M., Frey, N., Holtsberg, F. W., Aman, M. J., Fink, K., Diamond, M. S., Schieffelin, J. S., Crowe, J. E., Davidson, E., & Doranz, B. J. (2025). Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116098

Vancouver

Grinyo-Escuer A, Reddy S, Chenine AL, Whitbeck JC, Jacobsen S, Sheetz A, et al. Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116098

BibTeX
@article{GrinyoEscuer2025,
  author = {Grinyo-Escuer, Ariadna and Reddy, Srikar and Chenine, Agnes L and Whitbeck, J Charles and Jacobsen, Sonya and Sheetz, Allison and Doolan, Kyle and Norden, Diana M and Frey, Nolan and Holtsberg, Frederick W and Aman, M Javad and Fink, Katja and Diamond, Michael S and Schieffelin, John S and Crowe, James E and Davidson, Edgar and Doranz, Benjamin J},
  title = {Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116098}
}
Kostenlos starten →